#q1-2026
Latest news and interesting information about q1-2026.
Zomedica Q1 2026 sees record revenue growth
Zomedica Q1 2026 revenue hits record $8.8M, up 35% YoY. TRUFORMA adoption drives diagnostics growth. PIMS integration set for Sept 2026. Targets profitability by 2027.
QT Imaging Revenue Surges 133% in Q1 2026
QT Imaging Holdings Q1 2026 revenue surged 133% to $6.5M, but net loss and earnings miss led to an 11.59% stock drop.
Xunlei Q1 2026: Revenue Soars, Stock Climbs
Xunlei's Q1 2026 revenue surged 54% to $98.6 million. Stock price climbed to $5.95.
SQM Q1 2026 Revenue Beats Expectations, Stock Rises
SQM Q1 2026 revenue beats expectations, stock rises 4.85%. EPS misses but strong sales in lithium and iodine drive investor optimism.
Georgia Capital Q1 2026: Strong Growth
Georgia Capital PLC reported strong Q1 2026 results with revenue and EBITDA growth. Stock rose 2.03%. Read more on Bond.az.
FinVolution Q1 2026 Earnings Beat Estimates
FinVolution Group Q1 2026 earnings beat estimates. EPS $1.65, revenue $3.21B. Stock fell 6.07%. Full details on Bond.az.
Cementos Argos Misses Q1 EPS, Revenue Beats Forecast
Cementos Argos Q1 2026: EPS misses, revenue beats. US expansion and company split details. Stock falls 3.42%.
Atlas Engineered Products Misses Q1 2026 Forecasts
Atlas Engineered Products Q1 2026 financial results: EPS -0.02 CAD, revenue 9.3M CAD. Misses forecasts but remains optimistic.
Moltiply Group Q1 2026: Strong growth amidst market challenges
Moltiply Group Q1 2026 results: strong growth, energy sector challenges, and stock decline. Detailed information on the company's future prospects.
Atal SA strong Q1 2026 results
Atal SA reports strong Q1 2026 performance with revenue of PLN 314.8 million and 129% increase in handover volume.
Thryv Holdings Q1 2026 Beats Estimates, Stock Rises 4.64%
Thryv Holdings Q1 2026 earnings beat estimates: EPS $0.10 vs -$0.07, revenue $167.68M, stock up 4.64%. SaaS transformation on track.
Ceragon Q1 Revenue Beats by 5.77%
Ceragon Q1 2026 revenue of $85 million beats forecast of $80.36 million by 5.77%. EPS in line at $0.01.
Eurogroup Laminations Q1 2026: Mixed Results
Eurogroup Laminations reported mixed Q1 2026 results: revenue EUR 203.5M, stock up 0.75%. The company confirms full-year guidance. Read more on Bond.az.
Flowers Foods Q1 2026 EPS Beat, Revenue Miss
Flowers Foods Q1 2026 EPS beat estimates at $0.29, but revenue missed at $1.57 billion. Stock edged up in aftermarket. Dividend cut to reduce debt.
Cosan Q1 2026: Revenue Beats, EPS Misses
Cosan Q1 2026 earnings: revenue beat, EPS miss. Stock drops. Detailed analysis.
Mastech Q1 2026 Misses Estimates, Shares Fall
Mastech Holdings Q1 2026 results missed estimates: EPS $0.11, revenue $41.1M. Stock fell 12%. Company invests in AI and data platforms.
Austriacard Holdings: 61% Profit Surge in Q1
Austriacard Holdings Q1 2026 net profit surges 61%, beating expectations. Revenue up 8%, EBITDA margin at 12.9%. Stock jumps 18% in after-hours trading.
Navios Maritime Partners beats Q1 2026 expectations
Navios Maritime Partners Q1 2026 results: EPS $3.35, revenue $357 million. Stock up 2.33%. Read more on Bond.az.
ElvalHalcor Q1 2026 shows strong growth
ElvalHalcor Q1 2026 results: revenue EUR 1 billion, EBITDA up 33%, stock dips slightly.
BingEx Q1 2026 Earnings: Revenue Falls, Stock Dips
BingEx Q1 2026 earnings: revenue decline and stock drop. FlashEx brand reports financial results and future plans.
Cavendish Hydrogen Q1 2026: Revenue growth
Cavendish Hydrogen Q1 2026 revenue grew 47%, but profitability challenges persist.
Arcos Dorados Q1 2026 Beats EPS Forecasts
Arcos Dorados Q1 2026 EPS beats forecasts, stock surges 7.81%. Revenue hits $1.2 billion. Strong growth outlook.
Fermi America Q1 2026: $189M Loss Reported
Fermi America Q1 2026 reports $189M loss, revenue miss, and stock rise. Details on Project Matador and financials.
BioStem Misses Q1 2026 Earnings, Stock Drops 14.88%
BioStem Technologies misses Q1 2026 earnings, stock falls 14.88%. Hospital revenue stable. Company guides FY2026 revenue $25-$29 million.
WidePoint Q1 2026 Beats EPS Forecast, Stock Jumps 25%
WidePoint Q1 2026 beats EPS forecast with $0.01 per share, stock jumps 25% in after-hours trading. Revenue hits $40.6 million.
AuthID Q1 2026 Revenue Jumps 62%
AuthID Q1 2026 revenue jumps 62% to $480K, launches quantum-resistant biometric platform. Stock up 2.75% premarket.
CAVA Group Q1 2026: revenue beats, stock dips
CAVA Group Q1 2026 revenue beat forecasts, but stock fell. The company reported 32.2% revenue growth and strong new restaurant openings.
Cinclus Pharma Q1 2026 Revenue Milestone Boosts Stock
Cinclus Pharma Q1 2026 earnings: first revenue of SEK 10 million, stock up 4.08%. New partnerships and financing boost confidence.
Grupo Multilaser Q1 2026 reports robust growth
Grupo Multilaser reports strong Q1 2026 results with revenue and EPS growth, robust EBITDA, and positive cash flow. Strategic optimization and cost control drive performance.
Rubicon Organics Q1 2026 Earnings Miss, Stock Falls
Rubicon Organics Q1 2026 earnings miss: EPS of -0.04 CAD, revenue of 13.69 million CAD, stock down 11%. Company expects improvement in H2 2026.
...